1 hour ago
Revolution Medicines (RVMD) Stock Climbs After Early FDA Green Light for Pancreatic Cancer Treatment
Revolution Medicines (RVMD) stock gained after the FDA granted early approval to Rasonque for pancreatic cancer, with trial data showing significant survival benefits.
The post Revolution Medicines (RVMD) Stock Climbs After Early FDA Green Light for Pancreatic Cancer Treatment appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Market Movers Today: Nvidia (NVDA) Earnings, Inflation Jump, and Meta (META) Leg...
- 1 hour ago
Alibaba (BABA) Stock: Qwen Slashes AI Training Costs by 89% with New Qwen3.8-Fla...
- 1 hour ago
Meta (META) Stock: How Zuckerberg’s AI Workforce Strategy Crashed and Burned
- 1 hour ago
BofA: SpaceX Wireless Expansion Would Lift T-Mobile (TMUS) and Tower Stocks, Not...
- 1 hour ago
Citi Calls Oracle (ORCL) Stock’s 50% Plunge a Historic Buying Opportunity